Pliant Therapeutics, Inc.PLRXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-149M

+29.0% YoY

Free Cash Flow

$-129M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	8	10↑27.9%	2↓83.7%	0	0
Gross Profit	8	10↑27.9%	2↓83.7%	0	-2
Operating Income	-98	-127↓30.4%	-184↓44.8%	-228↓24.0%	-150↑34.3%
Net Income	-97	-123↓26.8%	-161↓30.8%	-210↓30.4%	-149↑29.0%
EBITDA	-96	-119↓24.2%	-158↓33.1%	-205↓29.7%	-148↑27.7%
EPS Diluted	-2.71	-2.94↓8.5%	-2.75↑6.5%	-3.47↓26.2%	-2.43↑30.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	52	34↓34.8%	63↑87.7%	71↑12.6%	45↓36.2%
Total Current Assets	209	340↑62.5%	506↑48.5%	362↓28.3%	196↓45.8%
Total Assets	221	351↑58.5%	512↑46.1%	397↓22.5%	225↓43.3%
Total Current Liabilities	17	24↑42.1%	29↑19.3%	33↑16.5%	16↓50.7%
Total Liabilities	22	37↑68.2%	39↑3.5%	93↑140.7%	44↓52.6%
Total Equity	199	313↑57.4%	474↑51.1%	304↓35.8%	181↓40.4%
Total Debt	7	16↑119.8%	11↓28.1%	60↑429.3%	29↓51.6%
Net Debt	-44	-18↑59.8%	-52↓190.2%	-11↑78.8%	-16↓48.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-75	-95↓25.4%	-116↓23.0%	-156↓33.6%	-128↑17.5%
Capital Expenditure	-2	-2↑9.9%	-1↑47.7%	-4↓317.8%	-0↑90.3%
Free Cash Flow	-77	-96↓24.5%	-117↓21.7%	-159↓35.9%	-129↑19.2%
Stock-Based Comp	10	23↑116.5%	44↑96.8%	38↓15.4%	26↓30.3%
Net Change in Cash	1	-18↓2396.4%	31↑272.6%	8↓74.4%	-26↓423.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance